Omecamtiv mecarbil not associated with improved exercise capacity compared with placebo in patients with chronic heart failure with reduced ejection fraction
1. In this randomized controlled trial, among 276 patients with chronic heart failure with reduced ejection fraction, omecamtiv mecarbil did ...


